✦ LIBER ✦

922 Adalimumab Maintains Long-Term Remission in Moderately to Severely Active Crohn's Disease Through 2 Years

✍ Scribed by Remo Panaccione; Jean-Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Geert D'Haens; Kathleen G. Lomax; Ju Li; Robert Wong; Paul F. Pollack

Book ID: 119428496
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 173 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(08)60622-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P148 - Adalimumab maintains long-term re

P148 - Adalimumab maintains long-term remission in patients with moderately to severely active Crohn's disease through 3 years of therapy

✍ R. Panaccione; J.F. Colombel; W.J. Sandborn; P. Rutgeerts; G. D'Haens; K.G. Loma 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 61 KB

P002 ADALIMUMAB MAINTAINS LONG-TERM REMI

P002 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE THROUGH 2 YEARS

✍ R. Panaccione; J.F. Colombel; W.J. Sandborn; P. Rutgeerts; G.R. D'Haens; K.G. Lo 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 134 KB

920 Adalimumab Maintains Long-Term Remis

920 Adalimumab Maintains Long-Term Remission in Moderately to Severely Active Crohn's Disease After Infliximab Failure: 1-Year Follow-Up of Gain Trial

✍ Remo Panaccione; William J. Sandborn; Geert D'Haens; Robert A. Enns; Douglas C. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 195 KB

W1092 Maintenance of Long-Term Remission

W1092 Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study

✍ Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Long-term safety and efficacy of adalimu

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

✍ Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 945 KB

P006 ADALIMUMAB MAINTAINS LONG-TERM REMI

P006 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE AFTER INFLIXIMAB FAILURE: 1-YEAR FOLLOW-UP OF GAIN TRIAL

✍ R. Panaccione; W.J. Sandborn; G.R. D'Haens; R. Enns; D.C. Wolf; K.G. Lomax; P.F. 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 92 KB